Vanguard Group’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783K | Buy |
1,151,023
+15,307
| +1% | +$10.4K | ﹤0.01% | 3819 |
|
|
2025
Q1 | $822K | Buy |
1,135,716
+233,185
| +26% | +$169K | ﹤0.01% | 3770 |
|
|
2024
Q4 | $862K | Hold |
902,531
| – | – | ﹤0.01% | 3810 |
|
|
2024
Q3 | $711K | Hold |
902,531
| – | – | ﹤0.01% | 3873 |
|
|
2024
Q2 | $855K | Hold |
902,531
| – | – | ﹤0.01% | 3852 |
|
|
2024
Q1 | $975K | Hold |
902,531
| – | – | ﹤0.01% | 3825 |
|
|
2023
Q4 | $496K | Buy |
902,531
+12,178
| +1% | +$6.7K | ﹤0.01% | 4029 |
|
|
2023
Q3 | $1.88M | Hold |
890,353
| – | – | ﹤0.01% | 3610 |
|
|
2023
Q2 | $2.33M | Hold |
890,353
| – | – | ﹤0.01% | 3607 |
|
|
2023
Q1 | $2.82M | Hold |
890,353
| – | – | ﹤0.01% | 3552 |
|
|
2022
Q4 | $2.4M | Sell |
890,353
-1,180
| -0.1% | -$3.17K | ﹤0.01% | 3600 |
|
|
2022
Q3 | $2.6M | Buy |
891,533
+472,368
| +113% | +$1.37M | ﹤0.01% | 3637 |
|
|
2022
Q2 | $1.22M | Buy |
419,165
+2,772
| +0.7% | +$8.09K | ﹤0.01% | 4014 |
|
|
2022
Q1 | $2.94M | Sell |
416,393
-7,831
| -2% | -$55.4K | ﹤0.01% | 3786 |
|
|
2021
Q4 | $6.79M | Buy |
+424,224
| New | +$6.79M | ﹤0.01% | 3445 |
|